Evidence map›Paper›PMID 36413541›Full record

ArticlePloS one2022

Role of DNA modifications in Mycoplasma gallisepticum.

Tatiana A Semashko, Alexander A Arzamasov, Daria V Evsyutina, Irina A Garanina, Daria S Matyushkina, Valentina G Ladygina, Olga V Pobeguts, Gleb Y Fisunov, Vadim M Govorun

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. A genome-wide investigation ofFrontiers in microbiology · 2025
    Article
  4. Article
  5. MinisculeSustainable microbiology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tatiana A SemashkoFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.ORCID 0000-0001-5389-2776
Alexander A ArzamasovFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.
Daria V EvsyutinaFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.
Irina A GaraninaFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.
Daria S MatyushkinaFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.
Valentina G LadyginaFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.
Olga V PobegutsFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.ORCID 0000-0001-5265-7627
Gleb Y FisunovFederal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation.
Vadim M GovorunResearch Institute for Systems Biology and Medicine, Moscow, Russian Federation.
InSysBio (Russia) · RUFederal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. Lopukhin · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epigenetics of bacteria, and bacteria with a reduced genome in particular, is of great interest, but is still poorly understood. Mycoplasma gallisepticum, a representative of the class Mollicutes, is an excellent model of a minimal cell because of its reduced genome size, lack of a cell wall, and primitive cell organization. In this study we investigated DNA modifications of the model object Mycoplasma gallisepticum and their roles. We identified DNA modifications and methylation motifs in M. gallisepticum S6 at the genome level using single molecule real time (SMRT) sequencing. Only the ANCNNNNCCT methylation motif was found in the M. gallisepticum S6 genome. The studied bacteria have one functional system for DNA modifications, the Type I restriction-modification (RM) system, MgaS6I. We characterized its activity, affinity, protection and epigenetic functions. We demonstrated the protective effects of this RM system. A common epigenetic signal for bacteria is the m6A modification we found, which can cause changes in DNA-protein interactions and affect the cell phenotype. Native methylation sites are underrepresented in promoter regions and located only near the -35 box of the promoter, which does not have a significant effect on gene expression in mycoplasmas. To study the epigenetics effect of m6A for genome-reduced bacteria, we constructed a series of M. gallisepticum strains expressing EGFP under promoters with the methylation motifs in their different elements. We demonstrated that m6A modifications of the promoter located only in the -10-box affected gene expression and downregulated the expression of the corresponding gene.

Indexed as

Mycoplasma gallisepticumTenericutesDNA, BacterialDNA MethylationDNA Restriction-Modification EnzymesDNA, BacterialDNA Restriction-Modification Enzymes

Identifiers

PMID36413541
PMCPMC9681074
OpenAlexW4309600500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.